VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 42 of Oncotarget features Figure 3, "Melanoma lung metastasis presenting CD73 staining in tumor cells (TC) and in tumor infiltrating mononuclear cells (TIMC)," by Monteiro, et al.
|
|
Table of Contents
Editorial
|
| p300 suppresses leukemia development in NUP98HOXD13 driven myelodysplastic syndrome |
|
https://doi.org/10.18632/oncotarget.23402
|
| 26603-26604 |
Research Papers
|
| Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells |
|
https://doi.org/10.18632/oncotarget.24902
|
| 26605-26615 |
|
| Association of genetic variants in ATRCHEK1 and ATMCHEK2 pathway genes with risk of colorectal cancer in a Chinese population |
|
https://doi.org/10.18632/oncotarget.24299
|
| 26616-26624 |
|
| Cryptotanshinone hinders renal fibrosis and epithelial transdifferentiation in obstructive nephropathy by inhibiting TGFβ1/Smad3/integrin β1 signal |
|
https://doi.org/10.18632/oncotarget.23803
|
| 26625-26637 |
|
| Antitumor roles of both strands of the miR455 duplex: their targets SKA1 and SKA3 are involved in the pathogenesis of renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25410
|
| 26638-26658 |
|
| CD73 expression and clinical significance in human metastatic melanoma |
|
https://doi.org/10.18632/oncotarget.25426
|
| 26659-26669 |
|
| Lymph node density in papillary thyroid carcinoma is a prognostic factor after adjusting for pathological stage |
|
https://doi.org/10.18632/oncotarget.25453
|
| 26670-26678 |
|
| An NFκBdependent mechanism of tumor cell plasticity and lateral transmission of aggressive features |
|
https://doi.org/10.18632/oncotarget.25465
|
| 26679-26700 |
|
| Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer |
|
https://doi.org/10.18632/oncotarget.25468
|
| 26701-26710 |
|
| Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.25475
|
| 26711-26723 |
|
| Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis |
|
https://doi.org/10.18632/oncotarget.25477
|
| 26724-26736 |
|
| Klotho inhibits EGFinduced cell migration in Caki1 cells through inactivation of EGFR and p38 MAPK signaling pathways |
|
https://doi.org/10.18632/oncotarget.25481
|
| 26737-26750 |
|
| miR146a suppresses 5lipoxygenase activating protein FLAP expression and Leukotriene B4 production in lung cancer cells |
|
https://doi.org/10.18632/oncotarget.25482
|
| 26751-26769 |
|
| Long noncoding RNA RAB11BAS1 prevents osteosarcoma development and progression via its natural antisense transcript RAB11B |
|
https://doi.org/10.18632/oncotarget.24247
|
| 26770-26786 |
|
| The dynamics of HER2 status in esophageal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.25507
|
| 26787-26799 |
|
| Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxiainduced acidification and clonogenic survival of cancer cells |
|
https://doi.org/10.18632/oncotarget.25508
|
| 26800-26816 |
|
| Nucleolin facilitates nuclear retention of an ultraconserved region containing TRA2β4 and accelerates colon cancer cell growth |
|
https://doi.org/10.18632/oncotarget.25510
|
| 26817-26833 |
|
| Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2V617Fexpressing leukemic cells including newly established PVTL2 |
|
https://doi.org/10.18632/oncotarget.25515
|
| 26834-26851 |
|
| SMAD proteins directly suppress PAX2 transcription downstream of transforming growth factorbeta 1 TGFβ1 signalling in renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25516
|
| 26852-26867 |
|
| Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.25525
|
| 26868-26883 |
|
| TNFAIP8 promotes prostate cancer cell survival by inducing autophagy |
|
https://doi.org/10.18632/oncotarget.25529
|
| 26884-26899 |
Reviews
|
| Liquid biopsy in pancreatic cancer: the beginning of a new era |
|
https://doi.org/10.18632/oncotarget.24809
|
| 26900-26933 |
|
| Aptamers: novelty tools for cancer biology |
|
https://doi.org/10.18632/oncotarget.25260
|
| 26934-26953 |
|
| Astroglial role in the pathophysiology of status epilepticus: an overview |
|
https://doi.org/10.18632/oncotarget.25485
|
| 26954-26976 |
Corrections
|
| Correction: Necrosisinducing peptide has the beneficial effect on killing tumor cells through neuropilin NRP1 targeting |
|
https://doi.org/10.18632/oncotarget.25604
|
| 26977-26977 |
|
| Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway |
|
https://doi.org/10.18632/oncotarget.25605
|
| 26978-26979 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
